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Angiopoietin-1 receptor Tie2 distinguishes
multipotent differentiation capability in
bovine coccygeal nucleus pulposus cells
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Abstract
Background: The intervertebral disc (IVD) has limited self-healing potential and disc repair strategies require an
appropriate cell source such as progenitor cells that could regenerate the damaged cells and tissues. The objective
of this study was to identify nucleus pulposus-derived progenitor cells (NPPC) and examine their potential in
regenerative medicine in vitro.
Methods: Nucleus pulposus cells (NPC) were obtained from 1-year-old bovine coccygeal discs by enzymatic
digestion and were sorted for the angiopoietin-1 receptor Tie2. The obtained Tie2– and Tie2+ fractions of cells
were differentiated into osteogenic, adipogenic, and chondrogenic lineages in vitro. Colony-forming units were
prepared from both cell populations and the colonies formed were analyzed and quantified after 8 days of culture.
In order to improve the preservation of the Tie2+ phenotype of NPPC in monolayer cultures, we tested a selection
of growth factors known to have stimulating effects, cocultured NPPC with IVD tissue, and exposed them to
hypoxic conditions (2 % O2).
Results: After 3 weeks of differentiation culture, only the NPC that were positive for Tie2 were able to differentiate
into osteocytes, adipocytes, and chondrocytes as characterized by calcium deposition (p < 0.0001), fat droplet
formation (p < 0.0001), and glycosaminoglycan content (p = 0.0095 vs. Tie2– NPC), respectively. Sorted Tie2– and
Tie2+ subpopulations of cells both formed colonies; however, the colonies formed from Tie2+ cells were spheroid
in shape, whereas those from Tie2– cells were spread and fibroblastic. In addition, Tie2+ cells formed more colonies
in 3D culture (p = 0.011) than Tie2– cells. During expansion, a fast decline in the fraction of Tie2+ cells was
observed (p < 0.0001), which was partially reversed by low oxygen concentration (p = 0.0068) and supplementation
of the culture with fibroblast growth factor 2 (FGF2) (p < 0.0001).
Conclusions: Our results showed that the bovine nucleus pulposus contains NPPC that are Tie2+. These cells
fulfilled formally progenitor criteria that were maintained in subsequent monolayer culture for up to 7 days by
addition of FGF2 or hypoxic conditions. We propose that the nucleus pulposus represents a niche of precursor cells
for regeneration of the IVD.
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Background
The intervertebral disc (IVD) has limited regenerative
potential and disc degeneration is a major cause of
chronic low back pain. This represents a leading cause
of disability with significant economic and social bur-
dens [1–3]. The IVD consists of an inner nucleus pulpo-
sus (NP) surrounded by the annulus fibrosus (AF) tissue,
and hyaline articular cartilage is located at the endplates
between the IVD and the vertebral bodies. The gelatin-
ous NP is an avascular tissue containing a highly orga-
nized extracellular matrix rich in proteoglycans and
collagens with few dispersed cells [4]. In this respect, the
NP cells reside within hypoxic conditions, since no vas-
culature enters the NP [5]. Furthermore, disc cells ac-
tively regulate the homeostasis of the extracellular
matrix by several cytokines and growth factors acting in
an autocrine and paracrine fashion. Members of the
transforming growth factor (TGF) superfamily, including
TGFβ1, growth and differentiation factor, fibroblast
growth factor 2 (FGF2), and vascular endothelial growth
factor (VEGF) were identified previously as anabolic reg-
ulators within the IVD [6].
IVD degeneration implies a degradation of the extra-
cellular matrix in the NP and the AF resulting in a re-
duced disc height. The exact mechanism by which IVD
degeneration is induced is still unknown. Some risk fac-
tors were identified and include aging, genetic predis-
position, and stress factors [7]. The degenerative
changes of the IVD take place early in life and the cellu-
lar turnover rate is much slower compared with other
tissues [8–10].
Current treatments aim to repair the degenerated disc
by replacement of the injured tissue with a functional
biological substitute or prosthesis. Conventional treat-
ments for IVD degeneration are limited, since conserva-
tive or surgical therapies do not restore IVD tissue
properties. Since the IVD possesses very limited healing
capacity, regenerative medicine by injection of cells may
represent promising therapy for treatment of disc degen-
eration [11]. As such, IVD repair strategies require an
appropriate cell source that is able to regenerate the
damaged NP tissue such as progenitor and stem cells.
Cell-based therapies by injection of IVD cells, chondro-
cytes, or stem cells have gained significant insight and
progressed to clinical trials for treatment of spinal disor-
ders [12]. Progenitor cells do have the advantage over
terminally differentiated cells that they maintain their
multipotent differentiation and self-renewal potential in
vivo and in vitro under appropriate conditions. Further-
more, these cells play an important role in the develop-
ment and homeostasis of the IVD tissue. Recently,
progenitor cells that are positive for the angiopoietin-1
receptor (Tie2) were identified in the mouse and human
NP [13]. These cells, which express aggrecan and
collagen type II, were shown to have progenitor-like
multipotency. Tie2, also known as CD202b, is a cellular
membrane receptor tyrosine kinase of the Tie family.
This receptor contains immunoglobulin-like loops and
an epidermal growth factor (EGF)-similar domain 2 [14].
Expressed mainly in endothelial cells, the angiopoietin
groups of ligands, upon binding to their receptor Tie2,
are known to regulate angiogenesis [15]. Tie2 signaling
appears to be critical for endothelial smooth muscle
communication and vascular maturation. Deletion of
Tie2 or its ligand in transgenic mice is embryonic lethal
and mice die from cardiac failure [16]. The contribution
of Tie2 to IVD homeostasis, however, is still poorly
understood. Here, we isolated primary nucleus pulposus
cells (NPC) from bovine coccygeal discs and sorted these
for the Tie2 marker, where the Tie2+ fraction of cells is
suggested to represent the nucleus pulposus progenitor
cells (NPPC) population. To demonstrate the stemness
of the Tie2+ cells, we performed differentiation assays
for the Tie2– and Tie2+ cell populations and then ad-
dressed their ability to form colonies in methylcellulose-
based medium. Presence of these NPPC has never been
demonstrated in bovine coccygeal IVD, a leading ex-vivo
animal model for studying disc degeneration and regen-
erative approaches [17]. A second aim was to address
the reported difficulties to maintain the phenotype of
NPPC in culture [13] and to test different cell culture
conditions to maintain and eventually expand these cells
in vitro in monolayer culture.
Methods
NPC isolation
NPC were obtained from 1-year-old bovine tail discs
within 4 hours post mortem (no ethical permit required)
by sequential digestion of NP tissue with 1.9 mg/ml pro-
nase (Roche, Basel, Switzerland) for 1 hour and 80 μg/
ml collagenase II (260 U/mg; Worthington, London,
UK) on a plate shaker at 37 °C overnight. The remaining
undigested tissue debris was removed by filtration
through a 100 μm cell strainer (Falcon, Becton Dickinson,
Allschwil, Switzerland); subsequently the cell viability was
determined by trypan blue exclusion. The isolated NPC
were used for further analysis.
Cell sorting and characterization by flow cytometry
To isolate the fraction of Tie2 expressing cells, NPC were
labeled as described previously [13]. Briefly, the NPC popu-
lation obtained after enzymatic digestion of 6-8 IVDs
(about 8 × 106 cells for one bovine tail) was resuspended in
100 μl of fluorescence-activated cell sorting (FACS) buffer
(phosphate-buffered saline containing 0.5 % bovine serum
albumin (Sigma-Aldrich, Buchs, Switzerland) and 1 mM
EDTA (Fluka, Buchs, Switzerland)) and was incubated with
anti-rat Tie2/CD202b polyclonal rabbit antibody (10 μg/ml,
Tekari et al. Stem Cell Research & Therapy  (2016) 7:75 Page 2 of 12
clone bs-1300R; Bioss Antibodies, Woburn, MA, USA) for
30 min at 4 °C. Incubation was performed for a further
30 min at 4 °C with goat anti-rabbit antibody (Molecular
Probes, Life Technologies, Zug, Switzerland) labeled with
the fluorochrome Alexa 488. Isotype-matched antibody
(Invitrogen, Life Technologies) was used as negative con-
trol to set the appropriate gate for positive Tie2 cells (Fig. 1).
Sorting was performed on FACS Diva III (BD Biosciences,
San Diego, USA); only living cells were considered by using
the propidium iodide (PI)-negative gate.
To characterize the NPC by Tie2 expression after ex-
pansion in monolayer culture, the cells were labeled in a
similar way. Briefly, 2 × 105 NPC in 100 μl of FACS buf-
fer were stained with the anti-rat Tie/CD202b antibody
for 30 min at 4 °C and further incubated with the goat
anti-rabbit secondary antibody for 30 min at 4 °C. Fluor-
escence was measured on an LSR II flow cytometry sys-
tem (Becton Dickinson), and the data were analyzed
using FlowJo software (version 10.1 for MacOS X; LLC,
Ashland, OR, USA).
NPPC proliferation
To identify proliferating cells, NPPC were expanded for
7 days in proliferation medium (alpha minimum essen-
tial medium (α-MEM; Gibco, Life Technologies) con-
taining 10 % fetal bovine serum (FBS; Sigma-Aldrich)
and penicillin/streptomycin (P/S, 100 units/ml and
100 μg/ml, respectively; Merck, Darmstadt, Germany)),
whereby 10 μM bromodeoxyuridine (BrdU) was added
at the beginning of the experiment with one medium
change. The incorporated BrdU was detected by flow cy-
tometry according to manufacturer’s instructions (APC
BrdU Flow Kit; Becton Dickinson).
Colony-forming assay
To assess the formation of colonies, single-cell suspensions
of 103 NPC were seeded in 1 ml of methylcellulose-based
medium (MethoCult H4230; Stem Cell Technologies,
Vancouver, Canada) in Petri dishes (35 mm in diameter)
and cultured for 8 days. The colonies formed (>10 nuclei)
were quantified under a light microscope.
Osteogenic differentiation
Differentiation of NPC into osteogenic lineage was per-
formed for cells immediately after digestion of the NP
and sorting for Tie2, and was conducted in α-MEM con-
taining 5 % FBS, P/S, 100 nM dexamethasone, 10 mM
β-glycerophosphate, and 0.1 mML-ascorbic acid-2-
phosphate (all from Sigma-Aldrich) for 21 days with
medium change twice a week. The serum concentration
was chosen according to a pilot study (data not shown)
showing a better differentiation of NPPC into osteogenic
lineage during the given time period. To evaluate the
cells’ ability for calcium deposition, Alizarin red staining
Fig. 1 Sorting and gating strategies for Tie2+ cells from a whole NPC population. The NPC suspension after enzymatic digestion was colabeled
with the Tie2 antibody and PI and sorted for the Tie2 marker. a, b Two examples show gating of the whole cell population for forward and side
scatter (FSC and SSC, P1; left panel). It is important to mention that primary NPC after enzymatic digestion contain tissue fragments, granules of
dead cells, and debris, which are removed by a selective gating for FSC and SSC (left panel, b). In addition doublets are excluded by a FSC-H
versus FSC-A gating (middle panel, b). Proper gating for Tie2 is shown for the two examples and was performed by a negative selection of cells in
isotype-matched control with less than 0.1 % (top right panel, P3) and setting the gate at the left for the Tie2– cells (P2). The same gating was
then applied for the specific Tie2 staining and by excluding PI-positive cells. P1 whole NPC population, P2 Tie2– cell population, P3 Tie2+ cell
population, PI propidium iodide, Tie2 angiopoietin-1 receptor
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was performed. The cell layers were fixed in 4 % formal-
dehyde, rinsed with distilled water, and subsequently ex-
posed to 2 % Alizarin red solution for 45 min. The
Alizarin red staining was released from the cell layers by
addition of 10 % cetylpyridinium chloride solution
(Sigma-Aldrich) and incubation for 1 hour with vigorous
agitation. The samples were diluted 10-fold, transferred
into a 96-well plate, and the optical density was mea-
sured at 570 nm using a microplate reader (SpectraMax
M5; Bucher Biotec, Basel, Switzerland).
Adipogenic differentiation
Immediately after digestion of the NP and sorting for
Tie2, NPC were grown in adipogenic medium consisting
of α-MEM with 5 % FBS, P/S, 12.5 μM insulin, 100 nM
dexamethasone, 0.5 mM isobutylmethylxanthine, and
60 μM indomethacin (all from Sigma-Aldrich) with
medium change twice a week. Adipogenic differentiation
was evaluated after 3 weeks of induction by the cellular
accumulation of lipid vacuoles that were stained with
Oil red O (Merck). The cell layers were fixed in 4 % for-
maldehyde, rinsed with 50 % ethanol, subsequently
stained with Oil red O solution for 20 min, and counter-
stained with Mayer’s Hematoxylin (Fluka) for 3 min.
The cellular accumulation of lipids was quantified from
the wells by counting the Oil red O-positive cells under
a light microscope.
Chondrogenic differentiation
The NPC were expanded in proliferation medium in 6-
well plates to compensate for the low number of Tie2+
cells obtained after sorting. Near confluency (1.93 ± 0.32
(mean ± SD) population doublings), the NPC were
resorted and the different NPC populations (Tie2–, Tie2
+, and unsorted NPC) were induced towards chondro-
genic differentiation. Briefly, 2.5 × 105 cells in Dulbecco’s
modified Eagle’s medium–high glucose (with 4.5 g/l glu-
cose; Gibco) containing P/S, ITS+, 0.1 mM L- ascorbic
acid-2-phosphate, 0.3 mM L-proline, 100 nM dexa-
methasone (all from Sigma-Aldrich), and 10 ng/ml
TGFβ1 (Peprotech, London, UK) were transferred into
15 ml polypropylene tubes and centrifuged at 500 × g for
5 min [18]. After 3 weeks of culture, the pellet cultures
were fixed with 4 % formaldehyde solution for 4 hours
at room temperature and embedded in paraffin for
subsequent preparation of 5 μm-thick sections. Sulfated
glycosaminoglycans (GAG) were stained with 0.2 %
Safranin-O for 10 min and sections counterstained with
0.04 % Fast Green for 2 min.
To quantify the GAG content, the pellets were recov-
ered by melting the paraffin blocks and subsequently
digested with a 3.9 U/ml papain solution containing
5 mM sodium citrate, 150 mM cysteine hydrochloride,
and 5 mM EDTA (Sigma-Aldrich) at 60 °C overnight.
The total GAG content was quantified from the lysates
using a bovine cartilage chondroitin sulfate standard
(Sigma-Aldrich) and normalized to the DNA content
(Picogreen ds DNA Assay kit; Molecular Probes, Life
Technologies).
Immunohistochemical staining for proteoglycans was
performed by incubation of the sections with a monoclo-
nal mouse anti-human proteoglycan antibody (10 μg/ml,
clone EFG-4; Millipore, Billerica, MA, USA) at 4 °C
overnight after permeabilization with 100 % methanol
for 2 min and blocking with 10 % FBS for 1 hour. Incu-
bation was performed for a further 1 hour with a goat
anti-mouse secondary antibody (Alexa 488; Molecular
Probes, Life Technologies). The tissues were visualized
with a confocal laser-scanning microscope (cLSM 710;
Carl Zeiss, Jena, Germany).
Expansion of Tie2+ cells and culture conditions
The freshly isolated Tie2+ cells after sorting were treated
with various growth factors and oxygen concentrations to
test for culture conditions that could amplify and maintain
the Tie2+ cells. Growth factors (Peprotech), including
growth differentiation factor 5 (GDF5), GDF6, EGF, VEGF,
FGF2 (100 ng/ml), and TGFβ1 (10 ng/ml), or coculture
with IVD tissue using culture inserts (Becton Dickinson)
for 6-well plates were applied to Tie2+ cells after sorting for
7 days in normoxia. The concentrations of the growth fac-
tors were selected according to previously published results
showing a beneficial effect on NPC and/or maintenance
and proliferation of stem cells in vitro [19–25]. Hypoxic
conditions at 2 % O2 have been shown in multiple studies
[26, 27], including by our group [19, 28], to have a stimula-
tory effect on aggrecan expression by NPC. To test for cell
proliferation and the conservation of Tie2 markers under
hypoxia, Tie2– and Tie2+ cells were cultured in normoxia
(atmospheric O2, ~21 %) or in hypoxia using a C-274-2
shelf chamber inside a standard incubator and 1× Pro-Ox
controller (Biospherix, Union Street Parish, New York,
USA) adjusted to 2 % O2 by addition of N2.
Real-time RT-PCR
Relative gene expression of Tie2 (TEK), collagen type II
(COL2), aggrecan (ACAN), hypoxia-inducible factor 1
alpha (HIF1α), and ribosomal 18S RNA as a reference
gene were monitored on expanded NPC. In order to de-
termine the baseline expression levels of selected genes,
bovine-specific oligonucleotide primers (Table 1) (Micro-
synth, Balgach, Switzerland) were newly designed with
Beacon Designer™ software (Premier Biosoft, Palo Alto,
CA, USA) based on nucleotide sequences from GenBank.
All primers were tested for efficiency and melting curves
of amplicons were performed to determine specific ampli-
fication. Relative gene expression was determined by ap-
plication of a threshold cycle and normalization to the
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reference sample (primary Tie2– NPC on day 0) using the
2–ΔΔCt method according to Livak and Schmitten [29].
Statistical analysis
Differences in the number of colonies (N = 6 animals),
BrdU-positive cells (N = 3), and expression of Tie2 (N = 3)
were evaluated by Student’s t test; histological quantifica-
tions (N = 5), levels of transcripts (N = 5), and Tie2+ cell
fractions (N = 3) were evaluated by one-way ANOVA with
Bonferroni’s post-hoc test, using GraphPad Prism (version
6.0 h for Mac OS; GraphPad Software Inc., La Jolla, CA
USA). p < 0.05 was considered significant.
Results
Sorting of Tie2+ cells from isolated NPC
The fraction of sorted Tie2+ cells after isolation of NPC
accounted for 8.66 ± 3.94 % (values presented as mean ±
SD) of the entire NPC population (N = 10 animals). The
amount of Tie2+ cells showed slight variation (variation
coefficient = 45.6 %) among the donors.
Differentiation of NPC in vitro
For the differentiation assays of NPC into osteogenic,
adipogenic, and chondrogenic lineages, we considered
the sorted Tie2– cells, the sorted Tie2+ cells, and a
mixed NP population of cells (unsorted) for comparison.
After 3 weeks of osteogenic induction, the cell layer
formed with Tie2– cells was negative for Alizarin red
and no calcium deposition was observed (Fig. 2). By
Table 1 Custom-designed DNA primers used in real-time
quantitative PCR study
Gene Forward sequence Reverse sequence
18S ACGGACAGGATTGACAGATTG CCAGAGTCTCGTTCGTTATCG
TEK GGACAGGCAATAAGGATACG ACCGAGTGGATGAAGGAA
COL2 CGGGTGAACGTGGAGAGACA GTCCAGGGTTGCCATTGGAG
ACAN GGCATCGTGTTCCATTACAG ACTCGTCCTTGTCTCCATAG
HIF1α AGGTGGATATGTCTGGATA CAAGTCGTGCTGAATAATAC
Amplicons were generated using a two-step amplification cycling (95 °C for
15 s and 57 °C for 30 s for 45 cycles) and SYBR-green mastermix
TEK angiopoietin-1 receptor gene, COL2 collagen type II gene, ACAN aggrecan
gene, HIF1α hypoxia-inducible factor 1 alpha gene, 18S ribosomal 18S RNA
Fig. 2 Osteogenic, adipogenic, and chondrogenic differentiation assays. a Differentiation assays were performed in Tie2– cells and Tie2+ cells
(i.e., NPPC) after sorting and a mixed cell population (unsorted NPC). Top panel Macroscopic and microscopic images of osteogenesis (Alizarin red
staining). Middle panel Adipogenic differentiation (Oil red O staining), arrows highlighting the formation of fat droplets. Lower panel Chondrogenic
differentiation: Safranin-O staining and proteoglycans (PG, green) immunohistochemistry counterstained with 4′,6-diamidino-2-phenylindole
(DAPI, blue). Results of one representative experiment of at least three repeats are shown. Scale bars are indicated on the images. b Quantification
of Alizarin red staining (ARS), Oil red O fat droplet-positive cells, and GAG/DNA content. Individual cell populations were cross-compared to determine
significance with *p < 0.05. Bars represent mean ± SD (N = 5). GAG glycosaminoglycans, Tie2 angiopoietin-1 receptor (Color figure online)
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contrast, Tie2+ cells deposited an extensive mineralized
matrix in osteogenic medium, as demonstrated by strong
Alizarin red staining (p < 0.0001). Interestingly, some
mineralized nodular formation was observed with a
mixed cell population; however, the amount of Alizarin
red staining did not significantly differ (p = 0.37) from
Tie2– cells. The adipogenic differentiation of NPC
showed that Tie2– cells could not form adipocytes; how-
ever, cellular accumulation of lipid vacuoles was detected
within the Tie2+ cells as demonstrated by a positive stain-
ing with Oil red O. The number of Oil red O-positive cells
was significantly higher in Tie2+ cells (p < 0.0001) as com-
pared with Tie2– cells. Some fat droplets were detected
within the culture of unsorted cells but to a lesser extent
compared with Tie2+ cells (p < 0.001). However, this did
not significantly differ from Tie2– cells (p = 0.85). For
chondrogenic differentiation, the tissue formed with Tie2–
cells stained very weakly for GAG (by Safranin-O) and
the cells showed a fibroblastic morphology. However,
the cultures with Tie2+ cells stained intensely for GAG
with lacunae formation observed, a characteristic of a
cartilaginous phenotype, and a higher GAG/DNA con-
tent (p = 0.0095) compared with Tie2– cells. Similarly,
the unsorted cells were able to form a cartilage-like tis-
sue, although staining was less intense compared with
the tissue of Tie2+ cells (p = 0.02). Similar results were
observed for the proteoglycan immunohistochemistry
staining, where the highest amount was detected within
tissue formed from Tie2+ cells and lower amounts were
observed for unsorted and Tie2– cells.
Colony formation
The Tie2– and Tie2+ isolated cell populations were able
to form colonies after 8 days of culture in methylcellulose-
based medium. However, the colonies formed with Tie2–
cells were spread, plastic adherent, and fibroblastic,
whereas the Tie2+ colonies formed were spheroid and
rounded as observed macroscopically (Fig. 3a). The
colonies of Tie2+ cells were quantitatively more abundant
(p = 0.011) compared with Tie2– colonies (Fig. 3b).
Proliferation of Tie2+ cells in monolayer cultures
After 3 days of culture, 18.49 ± 4.30 % of the NPPC were
positive for Tie2 (Fig. 4), while this fraction dropped to
0.61 ± 0.31 % after 7 days. The fraction of BrdU-positive
cells increased from 36.56 ± 1.01 % to 93.36 ± 1.56 %
when the cells were exposed to BrdU for 3–7 days. The
fraction of Tie2+ cells showed a higher proliferative cap-
acity on day 3 compared with Tie2– cells (69.2 ± 8.26 %
vs. 29.1 ± 8.26 %, values defined as the ratio of BrdU-
positive cells of total Tie2– or Tie2+ cells), while Tie2+
cells were less proliferative on day 7 (64.3 ± 13.4 % vs.
93.5 ± 1.52 %). Cells that incorporated BrdU were found
to be either Tie2+ or Tie2–.
Expression of Tie2 during expansion of NPC
The expression of Tie2 was monitored during expansion
of primary NPC in monolayer cultures. Therefore, Tie2–
and Tie2+ cells after sorting were plated in 6-well plates
at a density of 3 × 104 cells/well and kept in the prolifer-
ation medium for 7 days in a normoxia or hypoxia envir-
onment (2 % O2). The cells were harvested and
processed for flow cytometry analysis by staining for the
Tie2 marker. It was found that the fraction of Tie2+
cells was rapidly lost in monolayer cultures in both nor-
moxic and hypoxic conditions (Fig. 5), although culture
of the NPPC in hypoxic conditions better maintained
the Tie2+ pool of cells (3.34 ± 0.78 %) compared with
normoxia (0.83 ± 0.12 %). The proportion of Tie2+ cells
of the expanded Tie2– cells was nearly absent after
Fig. 3 Colony-forming assay of NPC versus NPPC. a Macroscopic images and (b) quantification of colonies (>10 cells) formed in Tie2– and Tie2+
cells after 8 days of culture in methylcellulose-based medium (N = 6). *p < 0.05 compared with Tie2– colonies. Tie2 angiopoietin-1 receptor
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7 days of culture, which accounted for 0.31 ± 0.08 % in
normoxia and 0.63 ± 0.14 % in hypoxic conditions. More
than 95 % of the cells were viable in both culture condi-
tions as detected by negative PI staining.
Gene expression
The isolated Tie2+ NPPC were cultured in the prolifera-
tion medium in the presence of various growth factors
or cocultured with IVD tissue for 7 days in normoxic
conditions. Alternatively, cells were cultured under hyp-
oxic conditions with/without FGF2. Treatment of the
cells with FGF2 (100 ng/ml) and/or culture under hyp-
oxic conditions resulted in a significant increase of TEK
gene expression to levels comparable with Tie2+ after
sorting (Fig. 6a). FGF2, EGF, VEGF (100 ng/ml), cocul-
ture with IVD tissue, and hypoxia increased collagen
type 2 (Fig. 6b) and aggrecan expression (Fig. 6c) com-
pared with Tie2– after sorting or cultures of NPPC for
7 days in normoxia without growth factor or IVD tissue.
No such effect was detected when NPPC were treated
with GDF5, GDF6 (100 ng/ml), or TGFβ1 (10 ng/ml).
HIF1α was significantly increased in hypoxic conditions
(Fig. 6d). A synergistic effect of FGF2 and hypoxia on
the transcript (Fig. 6a) and protein levels (Fig. 6e) of
Tie2 was observed.
Discussion
Cell-based treatment of disc degeneration represents a
promising approach to restore the IVD tissue function
and to relieve pain [30–32]. Extensive research in the
past decade using different animal models and clinical
trials has improved our knowledge on the effects of cell-
based therapies. In these studies, different cell types in-
cluding IVD-derived cells [33–35], chondrocytes [36–38],
and stem and progenitor cells [39–43] were used for
transplantation into the degenerated IVD either alone or
in combination with a biomaterial. The success rate of
such treatments was variable and highly dependent on the
model used, indicating that the selection of the cell source
is a crucial parameter for treatment of disc degeneration.
Bone marrow or adipose tissue-derived stem and progeni-
tor cells might have the advantage over committed cells in
Fig. 4 Proliferation of NPPC. Primary NPPC were labeled with BrdU for 3 and 7 days before the end of culture. a Incorporated BrdU, in
combination with surface-bound Tie2, was assessed using flow cytometry. b Proportion of each cell population determined from the scatter plot
quartiles (N = 3). *p < 0.05 compared with Tie2– cells. BrdU bromodeoxyuridine, Tie2 angiopoietin-1 receptor
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that they can be isolated in large quantities and without
donor site morbidity. Importantly, these cells possess mul-
tipotent properties and have a proliferative capacity, which
make these cells attractive for delivery into degenerated
discs. Preclinical studies showed that cells from the mes-
enchymal origin can participate in disc regeneration by
differentiating into chondrocyte-like cells and producing
NP tissue-specific extracellular matrix, namely aggrecan
and collagen type 2. Because NPC share some similarities
in phenotype and molecular content with cartilage-
specific cells, the chondrocytes [44], those cells with the
ability to differentiate into chondrocytes are considered a
potential target for the regeneration of the IVD tissue.
Resident progenitor cells within the IVD were docu-
mented previously [45–47]. Some of these cells were
shown to maintain multipotent and self-renewal potential
when cultured in vitro; however, little is known about
their role in the homeostasis of the IVD.
Within this study, we demonstrated that Tie2+ cells
from the bovine coccygeal discs are progenitor-like/
multipotent cells, which are able to differentiate into
osteogenic, adipogenic, and chondrogenic lineages in
vitro. Sakai et al. [13] were the first to identify NP
progenitor cells in the Tie2+ and disialoganglioside
Fig. 5 Expression levels of the surface-bound Tie2. a Expression levels of Tie2 after expansion for 7 days in monolayer cultures of Tie2– and Tie2+
cell (NPPC) populations in normoxic and hypoxic conditions were assessed using flow cytometry. b Quantification from the different scatter plot
quartiles. The NPC were costained with PI. *p < 0.05 compared with normoxia. Values are mean ± SD compared with the isotype control (N = 3).
PI propidium iodide, Tie2 angiopoietin-1 receptor
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2 positive (GD2+) cell fraction from human and mouse
IVD tissues. These cells were described to derive from
the Tie2+ and GD2– precursor cells and are capable of
differentiating into multiple mesenchymal and NP lin-
eages. GD2 was described as an additional marker for
progeny, whose expression is increased with activation
and commitment of the NP progenitor cells. In this
study, the expression of GD2 and its contribution to
differentiation of the disc cells was not investigated.
Our findings show the presence of Tie2+ NPPC in the
bovine coccygeal discs and further support previous re-
sults on NPPC in human and in mice [13, 48]. Addition-
ally, we showed that in contrast to Tie2–, only Tie2+ cells
have a multipotent potential as characterized by their dif-
ferentiation capacity in vitro and their ability to form
spheroid colonies. Tie2– cells within the disc tissue could
therefore be considered NP committed cells. The NPPC
may represent the key cells for the regenerative capacity
of the disc and maintenance of these cells could contrib-
ute to the homeostasis of the IVD.
NPPC were first described from human and mouse
IVDs [13]. Here, we could successfully isolate them from
bovine coccygeal IVDs. These IVDs have been estab-
lished as a reliable model to assess the biology and bio-
mechanics of the disc [49–51]. The present findings
allow further investigations and subsequent translation
into human samples, which are clinically more relevant.
Applying flow cytometry to detect the surface-bound
Tie2 marker allowed us to investigate the two phenotypes
present within a pool of expanded NPC. It should be
noted that setting the appropriate gate for Tie2 during
sorting of the NPC is highly sensitive and should be made
very stringent in order to avoid isolation of Tie2– cells,
which may not demonstrate multipotent differentiation
potential. In primary NPC, 8.66 ± 3.94 % of the cells
stained positive for Tie2. During expansion, the propor-
tion of Tie2+ cells was rapidly lost in subsequent mono-
layer cultures and less than 1 % could be detected after
2.31 ± 0.28 (mean ± SD) population doublings. In support
of our data are studies investigating molecular changes of
progenitor cells during in vitro monolayer cultures, where
they found that cellular morphology, self-renewal, and
differentiation capacity of these cells are altered during
expansion [52–54].
When the primary NPC were subjected to monolayer
cultures, they adhered and started to proliferate within a
few days. Because 8.66 ± 3.94 % of the freshly isolated
NPC population expressed Tie2, we wondered whether
the proliferating pool of cells comprised Tie2+ cells or
whether this pool is restricted to Tie2– cells. The
present data confirmed that proliferating cells showed
both Tie2+ and Tie2– phenotypes. These experiments
showed that cells harvested from the NP tissue are able
to maintain, at least for a short period, synthesis of Tie2
while proliferating in monolayer cultures. Furthermore,
we found that Tie2+ cells have a higher proliferative
capacity after 3 days compared with the Tie2– cell frac-
tion, while the Tie2+ fraction showed less proliferative
Fig. 6 Maintenance of NPPC (Tie2+) phenotype. Primary NPPC were stimulated with various growth factors (growth and differentiation factor 5
(GDF5), GDF6, transforming growth factor β1 (TGFβ1), fibroblast growth factor 2 (FGF2), epidermal growth factor (EGF), and vascular endothelial
growth factor (VEGF)), cocultured with IVD tissue or subjected to hypoxic conditions for 7 days, and the transcript levels of Tie2 were measured:
endothelial tyrosine kinase (TEK) (a), collagen type 2 (COL2) (b), aggrecan (ACAN) (c), and hypoxia-inducible factor 1 alpha (HIF1α) (d). Values are
mean ± SD (N= 5). *p < 0.05 compared with Tie2– of primary NPC. Protein level of Tie2 was monitored by flow cytometry in NPPC that were subjected
to hypoxic conditions and/or FGF2 (e). Values are mean ± SD (N = 3). *p < 0.05 compared with normoxic conditions. #p < 0.05 compared with
FGF2 + hypoxic conditions. IVD intervertebral disc, Tie2 angiopoietin-1 receptor
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activity on day 7. The proliferation dynamics of Tie2+
cells could therefore be explained by the massive in-
crease of the Tie2– pool of cells and the loss of the Tie2
+ fraction during expansion.
We addressed protocols for enrichment of Tie2+ cells
in vitro by application of growth factors known to be
beneficial for NPC or for inducing angiogenesis, by vary-
ing oxygen concentrations, or by coculture with IVD
tissue. Supplementation of the cultures with FGF2 in-
creased the TEK expression to levels similar to primary
Tie2+ NPC. FGF2 is known as a potent inducer of
angiogenesis [55] and was described as a crucial factor
for the successful maintenance of the undifferentiated state
and self-renewal of stem cells. Lotz et al. [56] reported that
stabilization of FGF2 using controlled poly(lactic-co-
glycolic acid) (PLGA) microsphere delivery improves
the expression of stem cell markers and cell amplifica-
tion, and decreases spontaneous differentiation. In
addition to FGF2, low oxygen concentrations (2 % O2)
better maintained the Tie2+ pool of cells compared with
normoxia; while simultaneous supplementation of the
cultures with FGF2 and hypoxic conditions showed a
synergistic effect and better maintained the Tie2 expres-
sion in NPPC after 7 days of culture. Physiological hyp-
oxic conditions were previously suggested to maintain
the undifferentiated state of many precursor cells, in-
cluding embryonic, hematopoietic, mesenchymal, and
neural stem cells [57]. Furthermore, cells of the IVD
reside within a hypoxic environment and are preserved
throughout their lifespan.
To characterize the NPPC during expansion, and fol-
lowing supplementation with various growth factors and
coculture with IVD tissue, we performed a gene expres-
sion analysis of two key genes for the NP, namely aggre-
can and collagen type 2. It was found that VEGF, EGF,
FGF2, or coculture with IVD increased the expression of
NP markers, suggesting the contribution of these factors
to differentiation of the NPPC towards the NP pheno-
type. Surprisingly, exposure of NPPC to recombinant
GDF5, GDF6, and TGFβ1 could not increase the expres-
sion of aggrecan or collagen type 2. An explanation may
derive from the fact that these factors might be active in
committed NPC rather than in progenitor cells. These
growth factors were shown previously to enhance the
discogenic phenotype of bone marrow-derived mesenchy-
mal stromal cells in vitro [21] while a stage-dependent
TGFβ1-induced chondrogenic differentiation of embry-
onic stem cells was observed [58].
Conclusions
The data presented herein demonstrate the presence of
a progenitor cell population within the NP expressing
the cell surface marker Tie2 and being able to differentiate
into osteogenic, adipogenic, and chondrogenic lineages
in vitro. Strategies to maintain the Tie2+ pool of the
NPC merit further evaluation, and sorting for Tie2
may contribute to a more suitable source for cell ther-
apy for regeneration of the IVD.
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